Trials / Completed
CompletedNCT05093101
The Prognostic Value of Serum Biomarkers in Osteosarcoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- —
Summary
Observational retrospective cohort study using laboratory data of blood tests prior to surgical and chemotherapy treatment and other histologic, clinical, and instrumental data related to patient history from digitized medical records and analysis of the same as predictors of outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | case series review of clinical data | Extraction of pre-surgical and chemotherapy blood test laboratory data and clinical and instrumental data related to patient history from digitized medical records and analysis |
Timeline
- Start date
- 2021-07-12
- Primary completion
- 2021-12-22
- Completion
- 2021-12-22
- First posted
- 2021-10-26
- Last updated
- 2022-04-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05093101. Inclusion in this directory is not an endorsement.